TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,064,000 | -49.2% | 337,609 | -8.0% | 0.05% | -41.0% |
| Q4 2021 | $17,839,000 | -32.4% | 366,837 | -7.7% | 0.08% | -34.5% |
| Q3 2021 | $26,406,000 | -21.3% | 397,502 | -7.6% | 0.12% | -17.4% |
| Q2 2021 | $33,572,000 | -13.0% | 430,300 | +1.0% | 0.14% | -15.8% |
| Q1 2021 | $38,579,000 | -17.2% | 425,873 | +11.4% | 0.17% | -35.0% |
| Q4 2020 | $46,596,000 | +19.6% | 382,411 | -13.1% | 0.26% | +30.8% |
| Q3 2020 | $38,946,000 | +37.5% | 439,823 | -0.7% | 0.20% | +24.8% |
| Q2 2020 | $28,315,000 | +459.1% | 442,714 | +290.4% | 0.16% | +403.1% |
| Q1 2020 | $5,064,000 | – | 113,407 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |